Literature DB >> 23630239

Drug patents: the evergreening problem.

Roger Collier.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23630239      PMCID： PMC3680578          DOI： 10.1503/cmaj.109-4466

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Limiting "evergreening" for a better balance of drug innovation incentives.

Authors:  Matthew B Stanbrook
Journal:  CMAJ       Date:  2013-07-22       Impact factor: 8.262

Review 2.  Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost.

Authors:  Abdul Salam; Mark D Huffman; Raju Kanukula; Esam Hari Prasad; Abhishek Sharma; David J Heller; Rajesh Vedanthan; Anubha Agarwal; Anthony Rodgers; Marc G Jaffe; Thomas R Frieden; Sandeep P Kishore
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-20       Impact factor: 3.738

Review 3.  Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine.

Authors:  Dean Ho; Chung-Huei Katherine Wang; Edward Kai-Hua Chow
Journal:  Sci Adv       Date:  2015-08-21       Impact factor: 14.136

4.  The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study.

Authors:  M Danta; N Ghinea
Journal:  J Virus Erad       Date:  2017-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.